The Traderszone Network

Published in TZ Latest News 3 November, 2017 by The TZ Newswire Staff

Sarepta Takes Another Big Step Forward With DMD Treatment

Sarepta Therapeutics saw its shares hit a new multiyear high on Friday after the firm announced that it received a key approval from the FDA.